These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31110180)
21. LNK deficiency aggravates palmitate-induced preadipocyte apoptosis. Du JY; Jin CC; Wang GH; Huang XQ; Cheng JD; Wen XJ; Zhao XM; Wang GL Biochem Biophys Res Commun; 2017 Aug; 490(2):91-97. PubMed ID: 28526415 [TBL] [Abstract][Full Text] [Related]
22. [Role of LNK gene mutation in pathogenesis of myeloproliferative neoplasms-review]. Chen Y; Wu XQ; Han CS; Zhu P; Wei JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1309-12. PubMed ID: 24156456 [TBL] [Abstract][Full Text] [Related]
23. Hematopoietic and eosinophil-specific LNK(SH2B3) deficiency promotes eosinophilia and arterial thrombosis. Dou H; Wang R; Tavallaie M; Xiao T; Olszewska M; Papapetrou EP; Tall AR; Wang N Blood; 2024 Apr; 143(17):1758-1772. PubMed ID: 38096361 [TBL] [Abstract][Full Text] [Related]
25. Metastatic melanoma cells evade immune detection by silencing STAT1. Osborn JL; Greer SF Int J Mol Sci; 2015 Feb; 16(2):4343-61. PubMed ID: 25690042 [TBL] [Abstract][Full Text] [Related]
26. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
27. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma. Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987 [TBL] [Abstract][Full Text] [Related]
28. Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Takizawa H; Kubo-Akashi C; Nobuhisa I; Kwon SM; Iseki M; Taga T; Takatsu K; Takaki S Blood; 2006 Apr; 107(7):2968-75. PubMed ID: 16332975 [TBL] [Abstract][Full Text] [Related]
29. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia. Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442 [TBL] [Abstract][Full Text] [Related]
30. Growth suppression by dual BRAF(V600E) and NRAS(Q61) oncogene expression is mediated by SPRY4 in melanoma. Kumar R; Njauw CN; Reddy BY; Ji Z; Rajadurai A; Klebanov N; Tsao H Oncogene; 2019 May; 38(18):3504-3520. PubMed ID: 30651601 [TBL] [Abstract][Full Text] [Related]
31. Selective Interference Targeting of Lnk in Umbilical Cord-Derived Late Endothelial Progenitor Cells Improves Vascular Repair, Following Hind Limb Ischemic Injury, via Regulation of JAK2/STAT3 Signaling. Lee SH; Lee KB; Lee JH; Kang S; Kim HG; Asahara T; Kwon SM Stem Cells; 2015 May; 33(5):1490-500. PubMed ID: 25537795 [TBL] [Abstract][Full Text] [Related]
32. Interferon alpha and CPG oligodeoxynucleotides elicit additive immunostimulatory and antitumor effects. Brown L; Roda J; Terrell C; Chaudhury AR; Crespin T; Carson WE; Lesinski GB Surgery; 2006 Aug; 140(2):297-306. PubMed ID: 16904983 [TBL] [Abstract][Full Text] [Related]
33. MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cells to targeted therapy. Juraleviciute M; Nsengimana J; Newton-Bishop J; Hendriks GJ; Slipicevic A Cancer Med; 2021 Apr; 10(8):2840-2854. PubMed ID: 33734579 [TBL] [Abstract][Full Text] [Related]
34. The Role of LNK (SH2B3) in the Regulation of JAK-STAT Signalling in Haematopoiesis. Morris R; Butler L; Perkins A; Kershaw NJ; Babon JJ Pharmaceuticals (Basel); 2021 Dec; 15(1):. PubMed ID: 35056081 [TBL] [Abstract][Full Text] [Related]
35. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421 [TBL] [Abstract][Full Text] [Related]
36. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma. Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024 [TBL] [Abstract][Full Text] [Related]
37. Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression. Katlinskaya YV; Katlinski KV; Yu Q; Ortiz A; Beiting DP; Brice A; Davar D; Sanders C; Kirkwood JM; Rui H; Xu X; Koumenis C; Diehl JA; Fuchs SY Cell Rep; 2016 Apr; 15(1):171-180. PubMed ID: 27052162 [TBL] [Abstract][Full Text] [Related]
38. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals. Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388 [TBL] [Abstract][Full Text] [Related]
39. Interferon-gamma, but not interferon-alpha, induces SOCS 3 expression in human melanoma cell lines. Kovarik A; Fojtova M; Boudny V; Adamkova L; Lauerova L; Kovarik J Melanoma Res; 2005 Dec; 15(6):481-8. PubMed ID: 16314732 [TBL] [Abstract][Full Text] [Related]
40. The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders. Maslah N; Cassinat B; Verger E; Kiladjian JJ; Velazquez L Leukemia; 2017 Aug; 31(8):1661-1670. PubMed ID: 28484264 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]